Keith Laemont MS, LATG

Prior to starting at the PTRU as our Operations Manager 3 years ago, I served 28 years as a preclinical pharmacologist/toxicologist in the biotechnology (Scios-Nova), pharmaceutical (Parke-Davis/Pfizer), and contract research organization (Alion Science & Technology, Charles River Laboratories, and SoBran BioScience) industries. I had the privilege to develop, characterize, and improve in vivo models to help discover treatments for COPD, inflammation, rheumatoid arthritis, osteoarthritis, fibromyalgia, pain, and cancer.


To learn more about the Duke Preclinical Translational Research Unit’s work or to get started, contact us